Sinovac and Sinopharm vaccines are now cheaper, thanks to price limits that kick off today!
Here is what you need to know…
Sinovac + Sinopharm Price Complaints : What’s Going On?
For some time now, people have been complaining about the prices of the Sinovac and Sinopharm vaccines, which ranged from RM95 to RM190 per dose.
Some even claimed that the Malaysian government used taxpayer’s money to purchase the Sinovac and Sinopharm vaccines, and questioned why they had to pay through the nose for them.
They are only offering the public the option to purchase the COVID-19 vaccine of their choice at private hospitals and clinics.
Sinovac + Sinopharm Price Limits Now In Effect!
After complaints of excessively high prices for Sinovac and Sinopharm vaccines, the government of Malaysia looked into the issue.
In a 13 January 2022 announcement, they agreed that the prices of COVID-19 vaccines offered by the private sector was too high, and set price limits for both vaccines.
|Sinovac CoronaVac||RM 62||RM 77|
|Sinopharm COVILO||RM 49||RM 61|
These price limits take effect today, Saturday, 15 January 2022, and do NOT include service charge and the cost of disposables used during the administration of the vaccine.
They also reminded the public that all private health facilities that were licensed to offer such private purchase vaccination are required to publicise their COVID-19 vaccine prices, so the public can easily make price comparisons.
The Malaysian government will continuously monitor the import and market price, and adjust the price limits over time.
Action will be taken against individuals or companies that fail to comply with these rules and price limits, under the Price Control and Anti-Profiteering Act 2011.
- Individual : Fine of up to RM100,000, or jail not exceeding three years, or both, or a RM50,000 compound
- Company : Find of up to RM500,000, or a compound of up to RM250,000
The public should submit complaints about any breaches to the Ministry of Health’s Public Complaints Management System (SISPAA) at https://moh.spab.gov.my.
Sinovac + Sinopharm Price Limits : Cheaper, Not Better
Now, I’m very happy that the government has finally set price limits for these vaccines. They were really expensive.
But even though these vaccines are now cheaper, they are still no better than they were before.
The truth is – Sinovac CoronaVac is not a good COVID-19 vaccine, which is why the National COVID-19 Immunisation Program (PICK) no longer offers it.
Even when it was first approved, the Sinovac vaccine offered just over 50% efficacy against symptomatic COVID-19. It was literally, the least efficacious COVID-19 vaccine in the world.
The massive RECoVaM study recently showed that its limited efficacy dropped precipitously after two months, with a big drop in protection against hospitalisation.
When we lacked access to better vaccines from Pfizer and AstraZeneca, the Sinovac vaccine was better than nothing.
But now that Malaysia has access to far superior COVID-19 vaccines, why should we settle for less effective vaccines?
Best of all – the government is offering superior COVID-19 vaccines from Pfizer and AstraZeneca for FREE!
So great, these vaccines are now cheaper… but why on Earth should you pay for less effective vaccines?
Do the smart thing – get vaccinated under the National COVID-19 Immunisation Program (PICK) for FREE!
- Did Shebby Singh Die From COVID-19 Booster Dose?
- No Travel Quarantine For Vaccinated COVID-19 Survivors!
- UOB Buys Citibank Malaysia, Indonesia, Thailand + Vietnam!
- Four Mega PPVs Offering Booster Dose In Klang Valley!
- All Petrol Stations Are Go To Safety Points, Not Just Shell!
If you like our work, please support us by visiting our sponsors, or donating to our fund. Thank you!